Abstract
Introduction Across Europe, the annual incidence of treated out-of-hospital cardiac arrest (OHCA) is 49 cases per 100,000 population. [1] Acute coronary syndrome (ACS) is a common cause of OHCA; where OHCA cause is recorded, approximately 76% of cases are attributed to cardiac aetiology. [2] Variation in OHCA mortality has been described between countries, Emergency Medical Service (EMS) systems and admitting hospitals. [1] [2] [3] Regional cardiac arrest centres have been proposed as a strategy to reduce inter-hospital variation in OHCA mortality, but the quality of evidence supporting the concept is low. [4, 5] Regionalised care systems are based on the premise that the benefit of immediate admission to a hospital with specialist facilities and expertise outweighs any risk associated with a potentially increased transport time. Such systems are already established in major trauma and stroke. [6, 7] In OHCA, improved understanding of inter-hospital variation in mortality is essential to improve understanding of the potential value of regionalised care systems. The availability in England and Wales of the only nation-wide ACS registry (Myocardial Ischaemia National Audit Project, MINAP) provides a unique opportunity to better understand these factors. Our study objective was to identify if there was evidence of inter-hospital variation in mortality among resuscitated cases of OHCA caused by ACS in the UK, and to identify the patient and health service factors that might contribute to any variation.
Methods

Data source
MINAP is a national registry of patients admitted to hospital with acute coronary syndromes.
Established in 1998, it provides a mechanism for participating hospitals to benchmark performance Page 5 against national standards. 
Patient eligibility
In this study, we included adult patients in the MINAP dataset where the initial cardiac arrest event occurred in the pre-hospital setting and where initial resuscitation attempts were successful leading to hospital admission. We excluded non-index (second or subsequent) cardiac arrests, events where the initial cardiac arrest event occurred in the in-hospital setting, and patients where the primary outcome was unknown.
Data definitions
For hospital-level data (volume, primary percutaneous coronary intervention (pPCI) capability, EMS distance), patients were categorised by the hospital to which they were first admitted. For hospital volume, the number of OHCA cases in each year at each hospital was calculated. Each patient was allocated to a volume category (low: 1-10 cases; medium: 11-24 cases; high: ≥25 cases) based on the hospital and year in which they were treated. We categorised patients as being treated in a pPCI capable hospital if it performed at least 100 pPCI procedures across all patients in the MINAP dataset in the year that the patient was admitted, as per UK guidance. [9] EMS distance was calculated as the Euclidian distance between the patient's home address and hospital. This assumed the OHCA event occurred at the patient's home, which is true for over 80% of UK OHCAs. [2] Page 6
Reperfusion treatment was categorised as early or late. Thrombolysis was classified as early if callto-needle time was up to 60 minutes, based on UK national standards. [10] PPCI was classified as early if door-to-balloon time was up to 90 minutes, based on the MINAP benchmark. [11] For sub-group analyses, we categorised patients, based on the MINAP variable 'ECG determining treatment,' as having STEMI (ST-elevation acute myocardial infarction or presumed new left bundle branch block (LBBB)) or NSTEACS (non-ST Elevation Acute Coronary Syndrome, which included all patients that did not meet the STEMI definition including unstable angina patients).
Outcome measures
The primary outcome was all-cause hospital mortality, as recorded in the MINAP dataset or, where this was incomplete, cross-referencing with ONS mortality data.
Sample size
Preliminary data supplied by MINAP led to a projected sample size of 14,310 eligible OHCA cases with a projected hospital mortality of 24%. Based on this, we calculated a 4% difference in mortality between categories within a predictor variable could be detected reliably with at least 90% power and a significance level of 0.05.
Statistical analysis
Multiple imputation using chained equations was used to reduce the bias associated with missing data in predictor variables (Supplementary Data Table S1 ), based on the approach used in previous MINAP analyses. [12, 13] Case identification and sub-group allocation was undertaken prior to imputation. Twenty-five imputed datasets were generated. Page 7 After imputation, an unadjusted random effects logistic regression model was fitted to predict hospital mortality and obtain the estimate for the log of the odds ratio and the standard error for each imputed dataset. The inclusion of a random effects term for the hospital enabled variation between hospitals to be modelled. Estimates from each of the 25 imputed datasets were combined using the Rubin's rules to get an overall odds ratio estimate of mortality, 95% confidence interval and p-value. [14] We adopted a similar approach for the adjusted analysis. The model included all clinically relevant predictor variables, unless there was evidence of multi-collinearity due to two predictors being highly correlated or a variable was clearly confounded by an unmeasured variable.
Alongside data from the whole cohort, we report data from STEMI and NSTEACS sub-groups, and Figure 1 ). Of these, 73875 (6.6%) were identified as having had a cardiac arrest. Sequential application of study exclusion criteria led to the exclusion of 56271 patients, most of whom had sustained an in-hospital cardiac arrest (N=50836, 90.3%). The study sample included data from 17604 patients across 239 hospitals. The median number of cases reported per hospital over the study period was 46 (range 1-517). Neurological outcome data were available for 15286 patients.
The number of cases included annually increased over the study period, with a peak of 2129 cases in 2012 (Supplementary Data Figure S1 ).
Patient characteristics (whole cohort)
Patients were predominantly male (n=13188, 75.1%) with a mean age of 65.3 years ( Table 1) . The most common co-morbidity was hypertension (n=6389, 41.0%). OHCA events typically occurred prior to EMS arrival (n=10533, 60.1%) with a shockable presenting rhythm (n=14778, 89.6%).
Most were classified as STEMI (n=12220, 71.9%), and were admitted to the coronary care Figure S2 ). Page 9 Length of stay and patient outcomes Overall hospital mortality was 28.7% (n=5047) and 40.9% (n=6245) died or were discharged with neurological deficit. In non-survivors, median time to death was 2 days (IQR 1-5, range 0-96) (Supplementary Data Figure S3 ). For survivors, median length of hospital stay was 7 days (IQR 3-14, range 0-372) (Supplementary Data Figure S4 ).
Variation in inter-hospital mortality
In the 94 hospitals that contributed at least 60 cases over the study period, hospital mortality by hospital ranged from 10.7% to 66.3% (median 28.6%, IQR 23.2% to 39.1%) (Supplementary Data Figure S5 ). (Table 2) .
Factors influencing mortality
Across the whole cohort, after co-variate adjustment, demographic factors associated with increased mortality included increasing age and social deprivation ( Table 2 ). Other factors associated with higher mortality included female gender, history of heart failure, increasing blood glucose, OHCA prior to EMS arrival, and STEMI or LBBB on the initial ECG. Hypertension, hypercholesterolaemia, and a shockable OHCA rhythm were associated with lower mortality. Table S4 ). Findings of these analyses were generally consistent with the primary analysis, albeit confidence intervals were typically wider. Point estimates for most reperfusion treatments in the complete case cohort indicated higher mortality, which may reflect a selection bias inasmuch as a complete dataset is likely easier to collect in patients that die.
Discussion
In this analysis of 17604 OHCA patients with ACS, admitted alive to 239 UK hospitals, just under three in ten died in hospital. Across the 94 hospitals contributing at least 60 cases, we identified wide variation in inter-hospital mortality. Modelling explained approximately one third of this variation. Over the 12-year study period, we observed changes in clinical practice, including increased admission of patients to pPCI capable hospitals and high-volume OHCA hospitals, and increased use of reperfusion treatment. The key modifiable factor associated with lower hospital mortality in STEMI patients was early reperfusion treatment.
Previous studies of OHCA have been inconsistent as to the association between hospital facilities, OHCA volume and outcome, which may be partly reflect variability in how these concepts are defined across the literature. [15] [16] [17] [18] In contrast to the findings of a recent analysis of the American Cardiac Arrest Registry to Enhance Survival dataset, we unexpectedly observed an association between admission to a pPCI capable hospital and higher mortality. [19] This finding may be partly Page 12 explained by case-mix differences between patients treated in pPCI and non-pPCI capable hospitals.
In particular, a higher proportion of patients in cardiogenic shock were admitted to pPCI capable hospitals, although the degree of missingness within this variable precluded its imputation and modelling.
The decisions by paramedics as to the most appropriate hospital to which to transfer a patient for ongoing treatment may be influenced by patient condition, hospital facilities, patient preference, local care pathways, and transfer time. Increased transfer time may increase the risk of clinical adverse events, but, in keeping with previous studies, we observed no harm associated with increasing transport distance. [15, 20] In line with previous ACS studies, we observed an association between increasing admission blood glucose and higher mortality. [21, 22] Active management of hyperglycaemia in ACS has been associated with improved outcome, [23] and is recommended in international guidelines. [24, 25] Our study did not analyse the medical management of hyperglycaemia, but our findings highlight a need for further research on this potentially modifiable clinical parameter.
Our findings indicate the widespread implementation of evidence-based guidelines for the immediate management of myocardial infarction following OHCA. [24, 25] Most STEMI patients (81.7%) and some NSTEACS patients (9.9%) received reperfusion therapy. In keeping with clinical trial data, early reperfusion treatment was associated with lower mortality in STEMI patients. [26, 27] We used the MINAP dataset to analyse outcomes in OHCA due to ACS. The key advantages to this dataset are national coverage and longevity. For the purpose of this study, its key limitation was that it does not capture key variables relevant to OHCA such as location (public v private) and bystander Page 13 CPR. Future studies may consider enriching MINAP data through linkage with other relevant UK datasets, such as the OHCA outcomes project and intensive care case mix programme. [2, 28] The OHCA outcomes project could provide key data on OHCA characteristics, but was established only in 2013 thereby limiting the opportunity for linkage. The intensive care case mix programme was established in the 1990s, but only approximately one in three patients in this study was admitted to the intensive care unit and the case mix programme does not directly collect provision of targeted temperature management although this may be derived from other variables. [29] Our study has the limitations inherent in all observational studies. In particular, despite its large size and use of complex statistical analyses, our findings may be affected by unmeasured residual confounders. A key challenge in analysing audit datasets such as MINAP is the management of missing data.
[13] Whilst we used sophisticated techniques to impute data, the degree of missingness in some important variables, such as Killip class, precluded this approach. Finally, there is known inter-hospital variation in methods used to identify patients for reporting to MINAP, particularly in NSTEACS patients, which may lead to selection bias. [11] Conclusions This large cohort study of patients with OHCA due to ACS found evidence of marked variation in mortality between hospitals, which was not fully explained by modelled patient and health service factors. Whilst we observed no association between cardiac arrest centre characteristics (volume, pPCI capability) and lower mortality, the early use of reperfusion treatment, which is likely to be available only in such centres, was associated with lower mortality in STEMI patients. 
